Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

about

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

Item

http://www.wikidata.org/entity/Q58750429

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@en

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@nl

type

Item

label

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@en

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@nl

prefLabel

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@en

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@nl

P1476

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer

@en

P2093

Eric Fox

http://www.w3.org/2001/XMLSchema#string

George C Prendergast

http://www.w3.org/2001/XMLSchema#string

Melissa Rowe

http://www.w3.org/2001/XMLSchema#string

Paul B Gilman

http://www.w3.org/2001/XMLSchema#string

Sunil Thomas

http://www.w3.org/2001/XMLSchema#string

Thomas Oliver

http://www.w3.org/2001/XMLSchema#string

P2860

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Prevention of allogeneic fetal rejection by tryptophan catabolism

The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells

IDO2 in Immunomodulation and Autoimmune Disease

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Tolerance, DCs and tryptophan: much ado about IDO

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

P304

370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00370

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yousef Zakharia

Alexander J Muller

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30254983

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6141803

http://www.w3.org/2001/XMLSchema#string